Form D · Other Technology

PHYTOFORM LABS INC.

Harpenden, Hertfordshire, X0 · CIK 0001874093

Offering snapshot reported Nov 24, 2021 · SEC filing

Reported sold
$5.75M
Offering amount: $5.75M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 7, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.88M$5.75MJul 22, 2021: $5,451,498.00Jul 22, 2021Nov 24, 2021: $5,754,777.00Nov 24, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,451,498 → $5,754,777

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 24, 2021Amendment$5,754,777$303,279vs Jul 22, 202115SEC filing
Jul 22, 2021Initial$5,451,498No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-407243
Total amount sold includes $1,501,500 in Convertible Simple Agreements for Future Equity (SAFEs).

Source: Form D, filed Nov 24, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicholas Kral Director
William Pelton Director, Executive
Dhiraj Singh Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
Lawes Open Innovation Hub West Common
Harpenden, Hertfordshire, X0, AL5 2JQ